title: Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.
abstract: Initial descriptions of the HIV engagement continuum are limited by short-term follow-up and incomplete data. We evaluated engagement in a newly HIV-diagnosed cohort. Our goals were to assess long-term engagement-in-care, evaluate the effects of out-of-state migration on engagement estimates, and determine whether engagement has improved in more recently diagnosed individuals. This is a retrospective cohort study of individuals newly HIV-diagnosed at two large HIV care centers in the Denver metropolitan area from 2005 to 2009. Clinical data were obtained from three public HIV providers and two clinical trial groups. For statewide evaluation, we used mandated laboratory reporting databases for CD4 lymphocyte counts and HIV-1 RNA levels. From 2005 to 2009, 615 individuals were diagnosed with HIV. By 18 months after HIV diagnosis, 84% of the cohort had linked to care, 73% were retained in care, 49% were prescribed antiretroviral therapy, and 36% had viral suppression. By 5 years after HIV diagnosis, 55% of the cohort were retained in care, 37% had viral suppression, 15% had moved out of state, and 3% were deceased. When censoring for outmigration and death, 66% of the cohort were retained in care and 45% of the cohort had viral suppression 5 years after HIV diagnosis. Engagement-in-care 18 months after diagnosis was better in individuals diagnosed more recently. Retention in care declined while viral suppression increased over time after HIV diagnosis. Accounting for outmigration and death significantly increased estimates of engagement-in-care. Performance in the engagement continuum 18 months after diagnosis improved significantly in individuals more recently diagnosed with HIV.
authors.affiliation: 1 Department of Infectious Disease, Denver Health and Hospital Authority , Denver, Colorado.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Rowan
authors.forename: William J
authors.initials: WJ
authors.lastname: Burman
authors.forename: Steven C
authors.initials: SC
authors.lastname: Johnson
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Connick
authors.forename: Daniel
authors.initials: D
authors.lastname: Reirden
authors.forename: Elaine
authors.initials: E
authors.lastname: Daniloff
authors.forename: Edward M
authors.initials: EM
authors.lastname: Gardner
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003120:Colorado / Q000453:epidemiology; D003266:Continuity of Patient Care; D003695:Delivery of Health Care; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D008297:Male; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D012959:Socioeconomic Factors; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load / Q000706:statistics & numerical data*
chemical_list: D044966:Anti-Retroviral Agents
references.citation: AIDS Patient Care STDS. 2009 Jan;23(1):41-9
references.pmid: 19055408
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):689-93
references.pmid: 21637182
references.citation: Soc Sci Med. 2003 Sep;57(6):1091-7
references.pmid: 12878108
references.citation: MMWR Morb Mortal Wkly Rep. 2010 Sep 24;59(37):1201-7
references.pmid: 20864920
references.citation: AIDS. 2010 Nov 13;24(17):2665-78
references.pmid: 20841990
references.citation: South Med J. 1994 Jun;87(6):599-606
references.pmid: 8202767
references.citation: AIDS. 2013 Sep 10;27(14):2271-9
references.pmid: 23669157
references.citation: N Engl J Med. 2011 Aug 11;365(6):493-505
references.pmid: 21767103
references.citation: AIDS Care. 2011 Nov;23(11):1366-73
references.pmid: 22022847
references.citation: AIDS Patient Care STDS. 2011 Feb;25(2):79-88
references.pmid: 21284498
references.citation: AIDS Patient Care STDS. 2013 May;27(5):287-96
references.pmid: 23651106
references.citation: Clin Infect Dis. 2011 Mar 15;52(6):793-800
references.pmid: 21367734
references.citation: AIDS Patient Care STDS. 2013 Aug;27(8):459-66
references.pmid: 23886048
references.citation: PLoS One. 2014 Feb 12;9(2):e87872
references.pmid: 24533061
references.citation: J Infect Dis. 2007 Apr 1;195(7):951-9
references.pmid: 17330784
references.citation: AIDS Res Hum Retroviruses. 2011 Jul;27(7):751-8
references.pmid: 21142607
references.citation: J Int Assoc Provid AIDS Care. 2013 Nov-Dec;12(6):384-90
references.pmid: 23962912
references.citation: AIDS. 2012 Jan 2;26(1):77-86
references.pmid: 22008656
references.citation: Sex Transm Dis. 2014 Jan;41(1):35-40
references.pmid: 24326579
references.citation: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):299-306
references.pmid: 23572013
references.citation: Am J Public Health. 2013 Jan;103(1):141-7
references.pmid: 23153150
references.citation: J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):86-93
references.pmid: 21937921
references.citation: Clin Infect Dis. 2007 Jun 1;44(11):1493-9
references.pmid: 17479948
references.citation: J Acquir Immune Defic Syndr. 2012 May 1;60(1):77-82
references.pmid: 22267016
references.citation: JAMA. 2008 Jul 2;300(1):51-9
references.pmid: 18594040
references.citation: J Urban Health. 2004 Sep;81(3):401-15
references.pmid: 15273264
references.citation: AIDS Educ Prev. 2005 Dec;17(6 Suppl B):39-48
references.pmid: 16401181
references.citation: Clin Infect Dis. 2011 Dec;53(11):1168-9; author's reply 1169-70
references.pmid: 21976466
references.citation: AIDS Care. 2006;18 Suppl 1:S51-8
references.pmid: 16938675